Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Generic Sweden AB (publ) on the sale of Generic Systems Sweden AB
Mandate

Vinge advises Generic Sweden AB (publ) on the sale of Generic Systems Sweden AB

June 21, 2017

Vinge advises Generic Sweden AB (publ), which is listed on First North, in connection with the sale of its consultancy business Generic Systems Sweden AB to MSC Group AB (publ). 

Generic Sweden's divestment of the consultancy business focuses the group's operations towards telecom. The purchase price consists of a cash component and shares in MSC Group AB (publ), which is listed on Nasdaq OMX Stockholm Small Cap.

The Vinge team advising Generic Sweden includes partners Jesper Ottergren (M&A) and Erik Sjöman (Capital Markets).

Related

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026

Vinge advises on the sale of Compab to Tången

 Vinge has advised the owners of Compab Energiteknik in connection with the sale of 80 per cent of the shares to Tången Industrikapital. Compab, which has a turnover of approximately SEK 100 million, sells, installs and services, amongst other things, steam and hot-water boilers as well as burners for the industrial sector.
October 26, 2026